Capricor Therapeutics, Inc.

DB:4LN2 Stock Report

Market Cap: €387.0m

Capricor Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:4LN2 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
20 Sep 24Buy€13,466,998Nippon Shinyaku Co., Ltd.Company2,798,507€4.81

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 4LN2?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders587,1111.29%
Public Companies4,944,42910.8%
Institutions18,553,23740.6%
General Public21,592,11047.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 43.7%.


Top Shareholders

Top 25 shareholders own 45.85% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.8%
Nippon Shinyaku Co., Ltd.
4,944,429€41.9m0%no data
6.45%
BlackRock, Inc.
2,944,665€24.9m-0.75%no data
4.96%
The Vanguard Group, Inc.
2,263,991€19.2m-0.56%no data
4.93%
Farallon Capital Management, L.L.C.
2,250,400€19.1m0%0.1%
4.03%
State Street Global Advisors, Inc.
1,842,800€15.6m-16.6%no data
1.97%
Geode Capital Management, LLC
901,379€7.6m2.49%no data
1.73%
Morgan Stanley, Investment Banking and Brokerage Investments
791,676€6.7m27.9%no data
1.6%
Woodline Partners LP
729,318€6.2m15.8%0.04%
0.93%
UBS Asset Management AG
426,841€3.6m173%no data
0.91%
Citadel Advisors LLC
415,951€3.5m56.8%no data
0.83%
Northern Trust Global Investments
379,773€3.2m-1.14%no data
0.81%
Goldman Sachs Group, Investment Banking and Securities Investments
367,817€3.1m46.4%no data
0.78%
Pier Capital, LLC
354,181€3.0m0%0.42%
0.61%
Black Diamond Financial, LLC
277,737€2.4m0%0.31%
0.53%
Superstring Capital Management LP
241,192€2.0m337%2.34%
0.52%
Avidity Partners Management, L.P.
239,000€2.0m0%0.4%
0.49%
Millennium Management LLC
222,070€1.9m92%no data
0.46%
Linda Marbán
212,024€1.8m6.26%no data
0.39%
Frank Litvack
176,117€1.5m-1.91%no data
0.37%
Squarepoint OPS LLC
171,213€1.5m534%no data
0.37%
Susquehanna International Group, LLP, Asset Management Arm
168,988€1.4m-39.9%no data
0.36%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
165,881€1.4m0%no data
0.35%
Leap Investments LP
159,200€1.3m0%0.02%
0.34%
Kennedy Capital Management LLC
153,487€1.3m6.4%0.03%
0.31%
PFM Health Sciences, LP
140,681€1.2m159%0.09%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/18 09:37
End of Day Share Price 2025/05/16 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Capricor Therapeutics, Inc. is covered by 9 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kristen KluskaCantor Fitzgerald & Co.
Joseph PantginisH.C. Wainwright & Co.
Catherine NovackJonesTrading Institutional Services, LLC